JP2006520359A - ヌクレオチド脂質エステル誘導体 - Google Patents

ヌクレオチド脂質エステル誘導体 Download PDF

Info

Publication number
JP2006520359A
JP2006520359A JP2006504723A JP2006504723A JP2006520359A JP 2006520359 A JP2006520359 A JP 2006520359A JP 2006504723 A JP2006504723 A JP 2006504723A JP 2006504723 A JP2006504723 A JP 2006504723A JP 2006520359 A JP2006520359 A JP 2006520359A
Authority
JP
Japan
Prior art keywords
group
alkoxy
alkyl
chloro
arabinofuranosyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006504723A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520359A5 (cg-RX-API-DMAC7.html
Inventor
ヘルマン,ディーター
ヘックル−エーズトライヒャー,ブリギッテ
ミューラー,クリストフ
ルッツ,クリスティアン
フォイグト,ロベルト
イー. バウタ,ウィリアム
Original Assignee
ハイデルベルク ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ハイデルベルク ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ハイデルベルク ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2006520359A publication Critical patent/JP2006520359A/ja
Publication of JP2006520359A5 publication Critical patent/JP2006520359A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2006504723A 2003-03-19 2004-03-18 ヌクレオチド脂質エステル誘導体 Pending JP2006520359A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45600303P 2003-03-19 2003-03-19
EP03006059A EP1460082A1 (en) 2003-03-19 2003-03-19 Phospholipid esters of clofarabine derivatives
PCT/EP2004/002810 WO2004083155A2 (en) 2003-03-19 2004-03-18 Nucleotide lipid ester derivatives

Publications (2)

Publication Number Publication Date
JP2006520359A true JP2006520359A (ja) 2006-09-07
JP2006520359A5 JP2006520359A5 (cg-RX-API-DMAC7.html) 2007-04-19

Family

ID=33031244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006504723A Pending JP2006520359A (ja) 2003-03-19 2004-03-18 ヌクレオチド脂質エステル誘導体

Country Status (21)

Country Link
US (1) US7419965B2 (cg-RX-API-DMAC7.html)
EP (2) EP1460082A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006520359A (cg-RX-API-DMAC7.html)
KR (1) KR20050109939A (cg-RX-API-DMAC7.html)
CN (1) CN100369926C (cg-RX-API-DMAC7.html)
AT (1) ATE328000T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004222163A1 (cg-RX-API-DMAC7.html)
CA (1) CA2519434A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105572T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004001047T2 (cg-RX-API-DMAC7.html)
DK (1) DK1606233T3 (cg-RX-API-DMAC7.html)
ES (1) ES2265636T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA05008817A (cg-RX-API-DMAC7.html)
NO (1) NO20053903L (cg-RX-API-DMAC7.html)
NZ (1) NZ542011A (cg-RX-API-DMAC7.html)
PL (1) PL1606233T3 (cg-RX-API-DMAC7.html)
PT (1) PT1606233E (cg-RX-API-DMAC7.html)
RU (1) RU2347786C2 (cg-RX-API-DMAC7.html)
SI (1) SI1606233T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004083155A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200507541B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021528465A (ja) * 2018-06-26 2021-10-21 ティーエスアールエル インコーポレイテッドTsrl,Inc. 代謝安定性プロドラッグ

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2070938A1 (en) 2007-12-13 2009-06-17 Heidelberg Pharma AG Clofarabine dietherphospholipid derivatives
CN102079766A (zh) * 2009-11-29 2011-06-01 海南中化联合制药工业股份有限公司 一种单磷酸阿糖腺苷的制备方法
CN101709073B (zh) * 2009-12-01 2013-01-23 北京大学 核苷酸磷脂分子及脂质体及其制备方法和应用
CN103232510B (zh) * 2012-11-23 2015-12-23 北京大学 5’-氨基-2’,5’-双脱氧核苷酸磷脂分子及其制备方法和应用
US9771385B2 (en) * 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
KR102371969B1 (ko) 2016-12-23 2022-03-08 주식회사 엘지에너지솔루션 배터리 모듈
WO2024059754A1 (en) * 2022-09-14 2024-03-21 Quantapore, Inc. Polythiolated linkers for stable nanoparticle suspensions and uses thereof
CN122180695A (zh) * 2023-10-29 2026-06-09 玛雅生物技术有限公司 靶向端粒的磷脂酰-thio缀合物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6383094A (ja) * 1986-09-27 1988-04-13 Toyo Jozo Co Ltd エ−テル型ヌクレオシド−リン脂質複合体
US5512671A (en) * 1993-02-16 1996-04-30 Wake Forest University Ether lipid-nucleoside covalent conjugates
JPH08512040A (ja) * 1993-07-01 1996-12-17 ベーリンガー マンハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング デオキシヌクレオシドのリポヌクレオチド、それらの製造方法および抗ウイルス薬としてのそれらの用途
JPH11512078A (ja) * 1995-06-07 1999-10-19 カール ワイ.ホステトラー 改良された生物学的利用能を有する医薬のプロドラッグ
WO2001034614A2 (en) * 1999-10-28 2001-05-17 Wake Forest University Compositions and methods for double-targeting virus infections and targeting cancer cells
WO2002087465A2 (en) * 2001-04-27 2002-11-07 Wake Forest University Compositions and methods of double-targeting virus infections and cancer cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US4751221A (en) 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
DE4026265A1 (de) 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
ATE292173T1 (de) * 1994-11-12 2005-04-15 Heidelberg Pharma Gmbh Lipidspaltender enzymkomplex

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6383094A (ja) * 1986-09-27 1988-04-13 Toyo Jozo Co Ltd エ−テル型ヌクレオシド−リン脂質複合体
US5512671A (en) * 1993-02-16 1996-04-30 Wake Forest University Ether lipid-nucleoside covalent conjugates
JPH08512040A (ja) * 1993-07-01 1996-12-17 ベーリンガー マンハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング デオキシヌクレオシドのリポヌクレオチド、それらの製造方法および抗ウイルス薬としてのそれらの用途
JPH11512078A (ja) * 1995-06-07 1999-10-19 カール ワイ.ホステトラー 改良された生物学的利用能を有する医薬のプロドラッグ
WO2001034614A2 (en) * 1999-10-28 2001-05-17 Wake Forest University Compositions and methods for double-targeting virus infections and targeting cancer cells
WO2002087465A2 (en) * 2001-04-27 2002-11-07 Wake Forest University Compositions and methods of double-targeting virus infections and cancer cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6010049169, J. Med. Chem., 1992, 35, 397−401 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021528465A (ja) * 2018-06-26 2021-10-21 ティーエスアールエル インコーポレイテッドTsrl,Inc. 代謝安定性プロドラッグ
JP7465416B2 (ja) 2018-06-26 2024-04-11 ティーエスアールエル インコーポレイテッド 代謝安定性プロドラッグ

Also Published As

Publication number Publication date
DE602004001047T2 (de) 2007-04-19
CN100369926C (zh) 2008-02-20
CA2519434A1 (en) 2004-09-30
US7419965B2 (en) 2008-09-02
DK1606233T3 (da) 2006-09-18
KR20050109939A (ko) 2005-11-22
RU2347786C2 (ru) 2009-02-27
DE602004001047D1 (de) 2006-07-06
ES2265636T3 (es) 2007-02-16
NO20053903L (no) 2005-12-19
EP1606233A2 (en) 2005-12-21
WO2004083155A3 (en) 2005-03-31
CN1771253A (zh) 2006-05-10
SI1606233T1 (sl) 2006-10-31
PL1606233T3 (pl) 2006-10-31
CY1105572T1 (el) 2010-07-28
NZ542011A (en) 2008-02-29
ATE328000T1 (de) 2006-06-15
WO2004083155A2 (en) 2004-09-30
NO20053903D0 (no) 2005-08-22
AU2004222163A1 (en) 2004-09-30
ZA200507541B (en) 2006-05-31
PT1606233E (pt) 2006-09-29
MXPA05008817A (es) 2005-10-18
EP1460082A1 (en) 2004-09-22
EP1606233B1 (en) 2006-05-31
RU2005130992A (ru) 2006-04-10
US20060293514A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
CN1032258C (zh) 新的核苷磷脂衍生物的制法
JP3802057B2 (ja) ヌクレオシド一リン酸の新規の脂質エステル及び免疫抑制薬としてのその利用
JP2501297B2 (ja) N4−(置換−オキシカルボニル)−5′−デオキシ−5−フルオロシチジン誘導体
JP4514242B2 (ja) 抗ウイルスピリミジンヌクレオシド類似体
AU780879B2 (en) Anti-viral pyrimidine nucleoside analogues
AU746170B2 (en) 5'-Deoxy-cytidine derivatives
EP1606233B1 (en) Phospholipid esters of Clofarabin
US6372725B1 (en) Specific lipid conjugates to nucleoside diphosphates and their use as drugs
ES2201805T3 (es) Nuevos gliceril-nucleotidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
WO2009074253A2 (en) Clofarabine phospholipid derivatives
JP2004505899A (ja) 5’−デオキシ−n−(置換されたオキシカルボニル)−5−フルオロシトシン及びその誘導体、その製造方法、並びに、これを有効性分として含む抗癌剤組成物
CA1319685C (en) 2'-methylidenepyrimidine nucleoside compounds, their use and method for production thereof
EP0517262A1 (en) Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same
JPWO2008010571A1 (ja) 2’−シアノピリミジンヌクレオシド化合物
HK1090060A (en) Nucleotide lipid ester derivatives
WO1995018138A1 (en) 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug
JPH06500543A (ja) ヌクレオシドの新規なリン脂質誘導体、それらの製造法、並びに抗ウイルス性医薬としてのそれらの使用
JPH08134093A (ja) 制癌剤
JPH05194518A (ja) 6−メルカプトプリン誘導体及びその製法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100831

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110208